ArticleThe Journal of investigative dermatology2014

DC-HIL+ CD14+ HLA-DR no/low cells are a potential blood marker and therapeutic target for melanoma.

Jake Turrentine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.